UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pharmacological Comparison of Mitragynine and 7-Hydroxymitragynine: In Vitro Affinity and Efficacy for μ -Opioid Receptor and Opioid-Like Behavioral Effects in Rats

The Journal of pharmacology and experimental therapeutics, 2021-03, Vol.376 (3), p.410-427

2021

Volltextzugriff (PDF)

The effects of mitragynine and morphine on schedule-controlled responding and antinociception in rats

Psychopharmacology, 2019-09, Vol.236 (9), p.2725-2734

2019

Volltextzugriff (PDF)

A single patient reported outcome measure for acquired brain injury, multiple sclerosis & Parkinson's disease

PloS one, 2021-06, Vol.16 (6), p.e0251484

2021

Volltextzugriff (PDF)

MORe PREcISE: a multicentre prospective study of patient reported outcome measures in stroke morbidity: a cross sectional study

BMC neurology, 2022-04, Vol.22 (1), p.145-145, Article 145

2022

Volltextzugriff (PDF)

A multi-centre, UK-based, non-inferiority randomised controlled trial of 4 follow-up assessment methods in stroke survivors

BMC medicine, 2019-07, Vol.17 (1), p.111-111, Article 111

2019

Volltextzugriff (PDF)

The Use of Patient Reported Outcome Measures (PROMs) 6 Months Post-Stroke and Their Association with the National Institute of Health Stroke Scale (NIHSS) on Admission to Hospital

Geriatrics (Basel), 2021-09, Vol.6 (3), p.88

2021

Volltextzugriff (PDF)

Acceptability of the method of administration of a patient-reported outcome measure (PROM) with stroke survivors, a randomised controlled trial protocol

Trials, 2018-07, Vol.19 (1), p.349-349, Article 349

2018

Volltextzugriff (PDF)

MORe PREcISE: Longitudinal patient reported outcome measures in stroke at 3 and 6 months

Journal of stroke and cerebrovascular diseases, 2024-12, Vol.33 (12), p.108023, Article 108023

2024

Volltextzugriff (PDF)

The Sigma 1 Receptor Antagonist CM304 Enhances the Antinociceptive Effects of the Cannabinoid Receptor Agonists, but not Mu‐Opioid Receptor Full Agonists in Mice

The FASEB journal, 2020-04, Vol.34 (S1), p.1-1

2020

Volltextzugriff (PDF)

Morbidity Prevalence Estimate at 6 Months Following a Stroke: Protocol for a Cohort Study

JMIR research protocols, 2020-06, Vol.9 (6), p.e15851-e15851

2020

Volltextzugriff (PDF)

Pharmacological Characterization of Mitragynine, the Primary Constituent in Kratom (Mitragyna Speciosa)

The FASEB journal, 2019-04, Vol.33 (S1), p.498.2-498.2

2019

Volltextzugriff (PDF)

CHILDREN AND THEIR DINNERS.; [TO THE EDITOR OF THE "SPECTATOR"]

The Spectator (London. 1828), 1883-10, Vol.56 (2887), p.1375

Pennington, Anna

1883

Volltextzugriff (PDF)

Integrating biomarkers across omic platforms: an approach to improve stratification of patients with indolent and aggressive prostate cancer

Molecular oncology, 2018-09, Vol.12 (9), p.1513-1525

2018

Volltextzugriff (PDF)

Sodium thiosulfate refuels the hepatic antioxidant pool reducing ischemia-reperfusion-induced liver injury

Free radical biology & medicine, 2023-08, Vol.204, p.151-160

2023

Volltextzugriff (PDF)

Reforms to improve reproducibility and quality must be coordinated across the research ecosystem: the view from the UKRN Local Network Leads

BMC research notes, 2022-02, Vol.15 (1), p.58-58, Article 58

2022

Volltextzugriff (PDF)

Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer

The New England journal of medicine, 2023-06, Vol.388 (23), p.2145-2158

2023

Volltextzugriff (PDF)

Identification and Evaluation of Serum Protein Biomarkers That Differentiate Psoriatic Arthritis From Rheumatoid Arthritis

Arthritis & rheumatology (Hoboken, N.J.), 2022-01, Vol.74 (1), p.81-91

2022

Volltextzugriff (PDF)

AcumenTM hypotension prediction index guidance for prevention and treatment of hypotension in noncardiac surgery: a prospective, single-arm, multicenter trial

Perioperative medicine (London), 2024-03, Vol.13 (1), p.13-13, Article 13

2024

Volltextzugriff (PDF)

Oral Apixaban for the Treatment of Acute Venous Thromboembolism

The New England journal of medicine, 2013-08, Vol.369 (9), p.799-808

2013

Volltextzugriff (PDF)

Patient-reported outcomes in the subpopulation of patients with mismatch repair-deficient/microsatellite instability-high primary advanced or recurrent endometrial cancer treated with dostarlimab plus chemotherapy compared with chemotherapy alone in the ENGOT-EN6-NSGO/GOG3031/RUBY trial

International journal of gynecological cancer, 2024-09, p.ijgc-2024-005484

2024

Volltextzugriff (PDF)

Fusion of HepG2 cells with mesenchymal stem cells increases cancer-associated and malignant properties: An in vivo metastasis model

Oncology reports, 2014-08, Vol.32 (2), p.539-547

2014

Volltextzugriff (PDF)

IL-27 maintains cytotoxic Ly6C+ γδ T cells that arise from immature precursors

The EMBO journal, 2024-07, Vol.43 (14), p.2878-2907

2024

Volltextzugriff (PDF)

Apixaban for Extended Treatment of Venous Thromboembolism

The New England journal of medicine, 2013-02, Vol.368 (8), p.699-708

2013

Volltextzugriff (PDF)

Healthcare utilization and costs in chronic cough

Current medical research and opinion, 2022-07, Vol.38 (7), p.1251-1257

2022

Volltextzugriff (PDF)

1 – 25 von 56

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(50)

Publikationsform

Sprache

Englisch
(56)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Pharmacological Comparison of Mitragynine and 7-Hydroxymitragynine: In Vitro Affinity and Efficacy for μ -Opioid Receptor and Opioid-Like Behavioral Effects in Rats

The effects of mitragynine and morphine on schedule-controlled responding and antinociception in rats

A single patient reported outcome measure for acquired brain injury, multiple sclerosis & Parkinson's disease

MORe PREcISE: a multicentre prospective study of patient reported outcome measures in stroke morbidity: a cross sectional study

A multi-centre, UK-based, non-inferiority randomised controlled trial of 4 follow-up assessment methods in stroke survivors

The Use of Patient Reported Outcome Measures (PROMs) 6 Months Post-Stroke and Their Association with the National Institute of Health Stroke Scale (NIHSS) on Admission to Hospital

Acceptability of the method of administration of a patient-reported outcome measure (PROM) with stroke survivors, a randomised controlled trial protocol

MORe PREcISE: Longitudinal patient reported outcome measures in stroke at 3 and 6 months

The Sigma 1 Receptor Antagonist CM304 Enhances the Antinociceptive Effects of the Cannabinoid Receptor Agonists, but not Mu‐Opioid Receptor Full Agonists in Mice

Morbidity Prevalence Estimate at 6 Months Following a Stroke: Protocol for a Cohort Study

Pharmacological Characterization of Mitragynine, the Primary Constituent in Kratom (Mitragyna Speciosa)

CHILDREN AND THEIR DINNERS.; [TO THE EDITOR OF THE "SPECTATOR"]

Integrating biomarkers across omic platforms: an approach to improve stratification of patients with indolent and aggressive prostate cancer

Sodium thiosulfate refuels the hepatic antioxidant pool reducing ischemia-reperfusion-induced liver injury

Reforms to improve reproducibility and quality must be coordinated across the research ecosystem: the view from the UKRN Local Network Leads

Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer

Identification and Evaluation of Serum Protein Biomarkers That Differentiate Psoriatic Arthritis From Rheumatoid Arthritis

AcumenTM hypotension prediction index guidance for prevention and treatment of hypotension in noncardiac surgery: a prospective, single-arm, multicenter trial

A Roadmap for Integrating Neuroscience Into Addiction Treatment: A Consensus of the Neuroscience Interest Group of the International Society of Addiction Medicine

Oral Apixaban for the Treatment of Acute Venous Thromboembolism

Patient-reported outcomes in the subpopulation of patients with mismatch repair-deficient/microsatellite instability-high primary advanced or recurrent endometrial cancer treated with dostarlimab plus chemotherapy compared with chemotherapy alone in the ENGOT-EN6-NSGO/GOG3031/RUBY trial

Fusion of HepG2 cells with mesenchymal stem cells increases cancer-associated and malignant properties: An in vivo metastasis model

IL-27 maintains cytotoxic Ly6C+ γδ T cells that arise from immature precursors

Apixaban for Extended Treatment of Venous Thromboembolism

Healthcare utilization and costs in chronic cough

Suchergebnisse filtern